By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Johannes Kepler University of Linz: Injection against heart attacks

David Bernhard © JKU

Taking action quickly can help to save lives. Researchers at the Johannes Kepler University of Linz are now developing an injection with which emergency physicians can save about 20 percent of the patient’s heart muscle from dying off. The new drug has already been successfully tested in the laboratory.

In the case of a heart attack, part of the heart is cut off from the oxygen supply. The surrounding heart tissue is not fully supplied with ultimately first ties after some time. This issue can be saved thanks to the new development of Prof. David Bernhard, Head of the Center for Medical Research at Johannes Kepler University of Linz. He developed a substance named 5`-Methoxyleoligin. The special property of this substance is that it not only protects the insufficiently supplied heart issue from the effects of the heart attack but can also be administered intravenously. Up until now treatment of the heart could first take place in a hospital within the context of a surgical procedure. Methoxyleoligin is originally derived from the roots of the edelweiss but can be synthetically produced in the meantime. All in all, experts from six Austrian universities worked on the project for several years under the leadership of the University of Linz.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Ukrainian-Austrian Business Forum

    27.4.2021/ 14.00 (CET) , Online Conference

  • Meet us @ Open Vienna - A Thriving Startup Ecosystem

    28.04.2021/ 9.15 am - 1.30 pm (CET), Online Conference

Austria Map

Find the perfect location for your company

A country like Austria considered to be an especially good terrain for upscale industrial segments, and with a particular emphasis on research and environmental friendliness, represents a major opportunity for SIAD. Our corporate goal is namely to assist the customer and provide support in improving the productivity and the environmental compatibility of its work processes.

SIAD

SIAD
More testimonials

news from the business location Austria

Medical University of Vienna and Vienna General Hospital: Expertise for lung transplants in cases of COVID-19

In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital performed a lung transplant on a 44-year-old patient who had been seriously ill with COVID-19, making her the first patient in Europe to receive a lung transplant for this indication.

Shared Mobility in Austria!

"A green planet with mobility from everyone, for everyone" has continuously been the motto of GO Sharing.

More news All blog posts